SMTL ID : 9f2h.2 (1 other biounit)

Crystal structure of SARS-CoV-2 N-protein C-terminal domain in complex with riluzole

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.30 Å

Oligo State

homo-dimer

Ligands

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 7 residues within 4Å: Chain A: T.81, G.82 Chain B: Q.28, T.29, T.79, Y.80, T.81 4 PLIP interactions: 1 interactions with chain A, 3 interactions with chain B Hydrogen bonds: A:G.82, B:Q.28, B:Q.28, B:Y.80

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain B: R.9, Q.19 2 PLIP interactions: 2 interactions with chain B Water bridges: B:R.9 Salt bridges: B:R.9

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Marquez-Monino, M.A. et al., The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity. Structure (2024)

Release Date

2024-11-13

Peptides

Nucleoprotein: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Nucleoprotein

Related Entries With Identical Sequence